financetom
Business
financetom
/
Business
/
Anbio Biotechnology Shares Rise After Nasdaq Debut
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Anbio Biotechnology Shares Rise After Nasdaq Debut
Feb 19, 2025 9:46 AM

12:22 PM EST, 02/19/2025 (MT Newswires) -- Anbio Biotechnology (NNNN) shares were up nearly 10% in recent Wednesday trading after the company's stock marked its Nasdaq debut at higher than the $5-per-share initial public offering price.

The company's shares were trading at $5.50 per share in recent trading after opening at $5.26.

The offering is expected to close on Thursday, the company previously said.

Price: 5.49, Change: +0.49, Percent Change: +9.80

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Molson Coors Beverage Company Up 0.6% In US Premarket As Proposes Public Offering of Euro-Denominated Senior Notes
Molson Coors Beverage Company Up 0.6% In US Premarket As Proposes Public Offering of Euro-Denominated Senior Notes
May 22, 2024
07:33 AM EDT, 05/22/2024 (MT Newswires) -- Molson Coors Beverage Company (TPX-A.TO, TPX-B.TO) on Wednesday commenced an underwritten public offering of euro-denominated senior notes. The Offering is expected to close on or about May 29, 2024, subject to customary closing conditions. Molson Coors said it intends to use the net proceeds of this Offering for general corporate purposes including the...
Medicenna to Present Clinical Update on MDNA11 ABILITY-1 Trial at Sachs Oncology Innovation Forum
Medicenna to Present Clinical Update on MDNA11 ABILITY-1 Trial at Sachs Oncology Innovation Forum
May 22, 2024
07:34 AM EDT, 05/22/2024 (MT Newswires) -- Medicenna Therapeutics ( MDNAF ) , whose shares rose 4.4% yesterday, on Wednesday said it will present an update on the MDNA11 ABILITY-1 Trial at the 10th annual Sachs Oncology Innovation Forum on May 31. The company will present updated data from its Phase 1/2 ABILITY-1 study including anti-tumor activity, safety, pharmacokinetic and...
Soccer-Oaktree has no immediate plan to sell Inter Milan, source says
Soccer-Oaktree has no immediate plan to sell Inter Milan, source says
May 22, 2024
MILAN, May 22 (Reuters) - U.S. investment fund Oaktree Capital Management is not planning to sell Inter Milan immediately after it took control of the Italian soccer club following a missed debt payment, a source close to the matter said. Oaktree will be a patient investor, the source added. Earlier on Wednesday the U.S. investment firm said it had taken...
Photronics Fiscal Q2 Adjusted Earnings, Revenue Fall; Sets Fiscal Q3 Outlook -- Shares Slump Premarket
Photronics Fiscal Q2 Adjusted Earnings, Revenue Fall; Sets Fiscal Q3 Outlook -- Shares Slump Premarket
May 22, 2024
07:19 AM EDT, 05/22/2024 (MT Newswires) -- Photronics ( PLAB ) reported fiscal Q2 adjusted earnings Wednesday of $0.46 per diluted share, down from $0.54 a year earlier. A single analyst polled by Capital IQ expected $0.55. Revenue for the quarter ended April 28 was $217 million, down from $229.3 million a year earlier. A sole analyst polled by Capital...
Copyright 2023-2026 - www.financetom.com All Rights Reserved